Michael Gelband’s Cimpress CMPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41M Buy
+13,863
New +$1.23M 0.01% 967
2025
Q4
Sell
-38,518
Closed -$2.43M 1614
2025
Q3
$2.43M Buy
38,518
+6,871
+22% +$385K 0.02% 668
2025
Q2
$1.49M Buy
+31,647
New +$1.38M 0.01% 843
2025
Q1
Sell
-29,954
Closed -$2.15M 1528
2024
Q4
$2.15M Buy
29,954
+9,655
+48% +$757K 0.01% 689
2024
Q3
$1.66M Buy
+20,299
New +$1.8M 0.01% 803
2024
Q1
Sell
-14,591
Closed -$1.17M 1545
2023
Q4
$1.17M Buy
+14,591
New +$1.02M 0.01% 759
2022
Q4
Sell
-8,279
Closed -$203K 1704
2022
Q3
$203K Buy
+8,279
New +$283K ﹤0.01% 1634
2021
Q4
Sell
-3,057
Closed -$265K 2210
2021
Q3
$265K Sell
3,057
-994
-25% -$97.5K ﹤0.01% 1667
2021
Q2
$439K Sell
4,051
-2,401
-37% -$243K ﹤0.01% 1530
2021
Q1
$646K Buy
6,452
+3,662
+131% +$361K 0.01% 1180
2020
Q4
$245K Buy
+2,790
New +$240K ﹤0.01% 1632
2020
Q3
Sell
-17,434
Closed -$1.33M 1805
2020
Q2
$1.33M Buy
+17,434
New +$1.24M 0.03% 601

Other funds holding CMPR

Michael Gelband's CMPR Position: Q2 2026 in Review

Michael Gelband opened a new position in Cimpress (CMPR) in Q2 2026: 13,863 shares worth $1.41M. The stake represents 0.01% of the portfolio and ranks #967 among its holdings. This is a return to the name: Michael Gelband previously reported a position in CMPR as recently as Q3 2025.

Michael Gelband first reported a position in CMPR in Q2 2020 and has held it in 12 quarters since. The position peaked at $2.43M in Q3 2025. 210 funds tracked by Wall St. Rank hold CMPR as of Q2 2026.

  • Michael Gelband held 13,863 shares of Cimpress worth $1.41M as of Q2 2026.
  • Cimpress was a new Michael Gelband position in Q2 2026.
  • Cimpress made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #967 holding.
  • Michael Gelband first reported a position in Cimpress in Q2 2020 and has held it in 12 quarters since.
  • Michael Gelband's Cimpress position peaked at $2.43M in Q3 2025.
  • 210 funds tracked by Wall St. Rank held Cimpress as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.